Morphine Sulfate
NDC Package 58177-310-11
Package Information
Morphine Sulfate is a medication used to treat severe pain. Marketed by Ethex Corporation, this product is identified by NDC 58177-310 and is authorized under FDA application ANDA076733.
Identification & Billing
- RxCUI: 891874 - morphine sulfate 100 MG Extended Release Oral Tablet
- RxCUI: 891874 - MS 100 MG Extended Release Oral Tablet
- RxCUI: 891881 - morphine sulfate 15 MG Extended Release Oral Tablet
- RxCUI: 891881 - MS 15 MG Extended Release Oral Tablet
- RxCUI: 891888 - morphine sulfate 30 MG Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58177 - Ethex Corporation
- 58177-310 - Morphine Sulfate
- 58177-310-11 - 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
- 58177-310 - Morphine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (58177-310). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58177-310-11 identifies a specific commercial package of 100 tablet, film coated, extended release in 1 blister pack of Morphine Sulfate, labeled by Ethex Corporation. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ethex Corporation on December 03, 2009. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.
How is this Ethex Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58177031011. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.